Stephan Dirnhofer - Department of Pathology, University Hospital of Basel

基本信息

浏览量：198

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 362 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Rapid Brain Lymphoma Diagnostics Through Nanopore Sequencing of Cytology-Negative Cerebrospinal Fluid

J. Hench, C. Hultschig, I. Bratic Hench, H. Sadasivan,Ö Yaldizli,G. Hutter,S. Dirnhofer,A. Tzankov,S. Frank

Acta Neuropathologicano. 1 (2024): 1-4

引用1浏览0WOS引用

The Impact of Genetic Subtypes of Diffuse Large B-Cell Lymphoma for Outcome Prediction and Interpretation of FDG-PET treatment Response Monitoring

Research Square (Research Square) (2023)

引用0浏览0引用

SAKK 38/19: ASSESSING A CTDNA AND PET‐ORIENTED THERAPY IN PATIENTS WITH DLBCL. A MULTICENTER, OPEN‐LABEL, PHASE II TRIAL

A. Stathis,F. Hitz,S. Schär,U. Novak,N. Fischer,U. Mey,G. Gritti,T. Zander,N. Lang,A. Cairoli,T. Zenz,G. Rhyner,W. Mingrone,A. Schmidt,G. Gaidano,S. Hohaus, A. O. Stern,C. Mamot, A. Bruscagin, J. Musilova,S. Hayoz,F. Bertoni,E. Zucca,S. Dirnhofer,L. Ceriani,D. Rossi

Hematological Oncologyno. S2 (2023): 165-166

引用1浏览0引用

Current management of mastocytosis: a single center experience

S. Ioakeimidou,S. C. Meyer, H. Wassmer, R. Battegay,J. R. Passweg,D. A. Tsakiris,S. Dirnhofer,A. Tzankov,K. Hartmann

SWISS MEDICAL WEEKLY（2023）

引用0浏览0引用

Supplementary Figures 1-8, Tables 1-2 from Akt/PKB-Mediated Phosphorylation of Twist1 Promotes Tumor Metastasis Via Mediating Cross-Talk Between PI3K/Akt and TGF-β Signaling Axes

Gongda Xue,David F. Restuccia,Qiang Lan,Debby Hynx,Stephan Dirnhofer,Daniel Hess,Curzio Rüegg,Brian A. Hemmings

openalex（2023）

引用0浏览0引用

Akt/PKB-mediated Phosphorylation of Twist1 Promotes Tumor Metastasis Via Mediating Cross-Talk Between PI3K/Akt and TGF-β Signaling Axes

Gongda Xue,David F. Restuccia,Qiang Lan,Debby Hynx,Stephan Dirnhofer,Daniel Hess,Curzio Rueegg,Brian A. Hemmings

pubmed（2023）

引用188浏览0WOS引用

188

SAKK 35/14 RANDOMIZED TRIAL OF RITUXIMAB WITH OR WITHOUT IBRUTINIB FOR UNTREATED PATIENTS WITH ADVANCED FOLLICULAR LYMPHOMA IN NEED OF THERAPY

B. Østenstad,M. C. Pirosa,S. Schär,M. Brodtkorb,B. E. Wahlin,M. Hernberg,M. Pedersen,A. Stathis,T. Zander,U. Novak,T. Zenz,N. Fischer,F. Krasniqi,F. Hitz, A. Jjohansson,D. Lofgren,P. Meyer, A. T. Bjørnevik,S. Hayoz, B. Scheibe, L. Steiner,S. Dirnhofer,L. Ceriani,E. Zucca

Hematological Oncologyno. S2 (2023): 117-119

引用0浏览0引用

Supplementary Figures 1 - 9, Table 1 from Microtubule-Depolymerizing Agents Used in Antibody–Drug Conjugates Induce Antitumor Immunity by Stimulation of Dendritic Cells

Philipp Müller,Kea Martin,Sebastian Theurich,Jens Schreiner,Spasenija Savic,Grzegorz Terszowski,Didier Lardinois,Viola A. Heinzelmann-Schwarz,Max Schlaak,Hans-Michael Kvasnicka,Giulio Spagnoli,Stephan Dirnhofer,Daniel E. Speiser,Michael von Bergwelt-Baildon,Alfred Zippelius

openalex（2023）

引用0浏览0引用

SHP2 targeting inhibits MAPK pathway activation and improves therapeutic effects of ruxolitinib in myeloproliferative neoplasms

S. Jungius, S. Mattei,S. Stivala,J. Szybinski,L. Vokalova,A. Rovo,A. Angelillo-Scherrer,S. Dirnhofer,S. Meyer

SWISS MEDICAL WEEKLY (2023): 40S-40S

引用0浏览0引用

Resistance to Type II JAK2 Inhibition via persistent MAPK Activation can be overcome by MEK Inhibition

T. Codilupi,J. Szybinski,S. Brkic,S. Stivala,J. L. Yang,A. Wicki,N. Ghosh,J. Passweg,S. Dirnhofer,R. L. Levine,R. Koche,S. C. Meyer

ONCOLOGY RESEARCH AND TREATMENTno. SUPPL 2 (2022)

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn